Global Health Policy & Government Affairs

Influencing the decision-makers who impact commercial outcomes

Maximising the commercial return and patient impact of great science requires life sciences organisations to shape policy and navigate complex stakeholder environments. With an experienced delivery team including former government leaders, Newmarket provides first rate counsel and implementation support.

The challenge

Making sense of a complex, fast-moving policy environment

Policy rarely moves in a straight line. Regulatory and legislative changes, shifting priorities in healthcare systems, and evolving international frameworks can disrupt commercial plans with little warning. The window to influence a decision is often short — and knowing who to engage, when, and with what message requires both deep political intelligence and genuine trusted relationships at senior levels.

It can sometimes feel easy to treat government affairs as an afterthought — reactive rather than strategic, disconnected from the commercial and access agenda. By the time the policy environment has shifted, the opportunity to shape it has already passed.

Our approach

Global health policy & government affairs expertise that understands both the science and the system

Our global health policy & government affairs team brings together specialists with deep experience across the pharmaceutical industry and international health organisations - people who understand how access, pricing and regulatory decisions actually get made in the markets that matter. We analyse the policy-related access barriers that shape commercial environments, account for international reference pricing, international reference policy dynamics and payer expectations across markets, and navigate the policy and clinical frameworks that determine uptake in each one.

That combination of technical rigour and consultancy discipline is what carries through to execution: policy, stakeholder and market access support that coordinates and drives launches across EU, US and international markets — global policy expertise, delivered with the precision of a specialist consultancy.

What we do

Strategic government affairs and global policy support

Our Government Affairs & Global Policy capability spans the full spectrum of public affairs and policy engagement — from intelligence-gathering, environmental analyses, and policy ideation through to campaign strategy and execution.

Strategic Government Affairs

Policy and stakeholder insight

Identifying new and emerging policy developments and the stakeholders who matter, when they matter, and how to reach them — across government, legislatures, healthcare systems and beyond.

Market and policy due diligence

Assessing the policy, commissioning and market dynamics that will shape future service adoption. Whether you are entering a new market, evaluating an opportunity, or stress-testing a strategy, we give you the intelligence to move with confidence.

Campaign strategy and implementation

Developing the narratives and campaigns that move stakeholders, build coalitions and change minds at decision-making level.

Issues management

Senior counsel on political risk, policy change and reputational matters — helping you manage and mitigate challenges before they emerge.

Global Policy

International policy analysis and horizon scanning

Analysis of policy-related access barriers that will shape your commercial environment.

Global access policy

Multi-market access and uptake policy that accounts for international reference pricing, IRP dynamics and payer expectations.

Multi-market uptake insight

Navigating the policy and clinical frameworks which impact uptake across multiple markets simultaneously.

Strategic support for international launches

Policy, stakeholder and market access support to coordinate and drive launches across EU, US and international markets.

how we work

From commercial insight to policy change

We begin by understanding your commercial objectives and the policy barriers that stand in your way — and develop comprehensive policy solutions to overcome them and engagement strategies to communicate with the decision-takers who matter.

0

Map your commercial objectives to the policy landscape

We assess the system-level, reimbursement and clinical barriers that obstruct the use of new innovations – and understand where in the policy landscape options to overcome them exist, and how to create opportunities when they do not.

0

Build your stakeholder & campaign strategy

We develop clear, actionable engagement plans — who to reach, through what channels, with what messages — to link you with the stakeholders who can help drive the policy changes you need.

0

Engage with credibility & confidence

We facilitate direct engagement with senior decision-makers — drawing on our team's relationships, credibility and track record at the highest levels of public policy.

0

Build coalitions & sustain advocacy

We help build the clinical, patient, academic and industry coalitions that amplify your voice and embed your innovations within the long-term policy agenda.

The outcome

Shaping the policy decisions that determine success

Our clients consistently rate our strategic insights and policy capability as unmatched. Our team has advised prime ministers, guided government life sciences strategies, and brokered multi-billion dollar deals between industry and government authorities.

6

Senior leaders who have operated at the highest levels of government health policy

50+

Years advising global life sciences businesses

81

Net Promoter Score from Newmarket's 2026 client feedback exercise

Our team

Practical advice from people who understand the market

Newmarket Strategy brings together market access specialists, healthcare policy experts, clinicians, analysts and commercial strategists.

James O'Shaughnessy
Senior Partner
Team
One of the UK's leading policy advisors. Operated at the highest levels of government as a Minister at the Department for Health & Social Care, Director of the No.10 Policy Unit, and advisor to DHSC Ministers during COVID-19.
James O'Shaughnessy
Senior Partner
Bill Morgan
Senior Partner
Team
Has advised Prime Ministers, health ministers and leading life sciences businesses for over two decades. Before joining Newmarket, served as No.10's Special Adviser for Health, Social Care and Life Sciences.
Bill Morgan
Senior Partner
Catarina Casella
Partner
Team
Catarina advises life sciences companies, patient organisations and healthcare stakeholders on navigating complex health policy challenges, with more than seven years' experience in health policy and public affairs.
Catarina Casella
Partner
Kieran Lucia
Partner
Team
Kieran brings deep expertise in global pricing policy and health systems, with a strong track record advising life sciences companies on market access policy, patient pathways and health policy strategy across international markets.
Kieran Lucia
Partner
Paul Blakeley
Director
Team
Paul has deep expertise in health and life sciences policy, from early-stage research and development, through to market access, adoption and spread of innovation.
Paul Blakeley
Director
Charlie Norell
Director
Team
Charlie brings over a decade of policy experience spanning HealthTech, biopharma, the NHS, and life sciences venture capital. He advises health and life sciences businesses and investors on policy, regulatory, and market access challenges, both in the UK and globally.
Charlie Norell
Director
Sebastian Phillips
Senior Manager
Team
Seb joined Newmarket Strategy as a Senior Consultant (Government Affairs) in November 2024, following 4 years of experience at Government Affairs and Market Access agency, PLMR Healthcomms, where he engaged with the NHS, Whitehall and Parliament to improve the uptake of innovative technologies and outcomes for patients.
Sebastian Phillips
Senior Manager
Olivia Lay
Senior Manager
Team
Olivia joined Newmarket Strategy in 2025, bringing several years of experience in life sciences consulting, where she partnered with global pharmaceutical clients to design and implement R&D, clinical development, and organisational strategies.
Olivia Lay
Senior Manager
Valerie Jentzsch
Manager
Team
Valerie is a Manager at Newmarket, leading policy and government affairs work for global pharmaceutical clients.
Valerie Jentzsch
Manager
Janie Mullaney
Manager
Team
Jane joined Newmarket Strategy as Strategic Government Affairs consultant with a postgraduate degree in History from Oxford University and a year of health consultancy experience, where she worked with clients to deliver on communication and policy-related objectives.
Janie Mullaney
Manager

Related case studies

Continue reading

Global Health Policy & Government Affairs
1
min read

Shaping the national policy framework for technology adoption

A globally leading medical technology company had a transformative technology but no national policy framework to drive its adoption at scale. Newmarket Strategy designed and led a government affairs programme that took the technology from the periphery of national healthcare policy to the heart of Government's transformation agenda.

18 September 2026
Global Health Policy & Government Affairs
1
min read

Securing a landmark strategic partnership with the UK government

We helped a major pharmaceutical company win a highly competitive landmark strategic partnership with the UK government to transform how a major disease is prevented, diagnosed and treated.

15 September 2026
Global Health Policy & Government Affairs
1
min read

Shaping the national policy framework for technology adoption

A globally leading medical technology company had a transformative technology but no national policy framework to drive its adoption at scale. Newmarket Strategy designed and led a government affairs programme that took the technology from the periphery of national healthcare policy to the heart of Government's transformation agenda.

September 18, 2026
Global Health Policy & Government Affairs
1
min read

Securing a landmark strategic partnership with the UK government

We helped a major pharmaceutical company win a highly competitive landmark strategic partnership with the UK government to transform how a major disease is prevented, diagnosed and treated.

September 15, 2026

Don't just take our word for it

“They have a lot of people who worked in government and have expertise within the NHS; they know it’s technical and there is no waffle; they have a good feel for what we need.”

Health System Client
Medical technology company

“The quality of insights in terms of understanding the government and health system thinking: it’s unmatched due to the quality of the senior team.”

Senior Partner
Life sciences organisation

“They are clearly content experts above all else. Their external relationships are second to none, and I’m impressed by how they maintain that.”

Policy & Public Affairs Client
Medical technology company

What we do

Pillars of our expertise

Newmarket Strategy has industry-leading expertise supporting market access strategy through policy, reimbursement and evidence synthesis.

0

Value & Access

Empowering organisations to set commercial strategy, demonstrate value and secure reimbursement.

0

Global Health Policy & Government Affairs

Helping organisations navigate complex political landscapes, influence decision makers, and shape health policy.

0

Health Economics & Evidence Synthesis

Harnessing robust data and economic modelling to build a compelling evidence base and drive market uptake.